Opendata, web and dolomites
H2020 projects about "bowel"
The page lists 66 projects related to the topic "bowel".
| # | |||
|---|---|---|---|
| 1 | EPIMAC | The next generation epigenetic medicine for inflammation | 2015 |
| 2 | GLYCO-TOOLS | Bio-Inspired Tools for Glycoscience | 2015 |
| 3 | GutILC3 | Cell-cell interactions critical to ILC3 function in the human gut | 2015 |
| 4 | WORMTUMORS | Worm power: Can helminths modify the development of colorectal cancer? | 2015 |
| 5 | IPEIBD | Identification of promoters and enhancers specific for inflammatory bowel disease and its subtypes | 2015 |
| 6 | KCs and Gut Antigens | Elucidating the role of liver resident Kupffer cells in the regulation of the immune responses to intestinal antigens | 2015 |
| 7 | MD | Rapid monitoring of biomarkers in postoperative care | 2015 |
| 8 | IMMUNOBIOME | Identifying microbiotal triggers of inflammatory bowel disease through the lens of the immune system | 2016 |
| 9 | LeukoTheranostics | Harnessing Targeted Nanotheranostics to Reprogram Activated Leukocytes in Inflammatory Bowel Disease | 2015 |
| 10 | PERIF | Perivascular cells at the crossroads of inflammation, regeneration and fibrosis | 2015 |
| 11 | TETRA | Autologous Stem Cell Seeded Tissue Engineered Trachea | 2016 |
| 12 | TACTICS | Transferring Activomics into the Clinical Setting | 2015 |
| 13 | PIBD-SETQuality | Paediatric Inflammatory Bowel Diseases Network for Safety, Efficacy, Treatment and Quality improvement of care | 2016 |
| 14 | INTENS | INtestinal Tissue ENgineering Solution | 2016 |
| 15 | CF_struct | High-Resolution X-ray Structures of Full-Length Cystic Fibrosis Transmembrane Conductance Regulator | 2016 |
| 16 | StemHealth | Foetal Intestinal Stem Cells in Biology and Health | 2016 |
| 17 | CrUCCial | Novel diagnostic and therapeutic approach to inflammatory bowel disease based on functional characterization of patients: the CrUCCial index | 2016 |
| 18 | Pectin | The microbial degradation and utilization of complex pectins by Bacteroides in the human intestine | 2016 |
| 19 | NEW DEAL | New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases | 2017 |
| 20 | GUTPEPTIDES | Novel therapeutic approaches to improve gastrointestinal wound healing | 2017 |
| 21 | SYSCID | A Systems medicine approach to chronic inflammatory disease | 2017 |
| 22 | MODulATE | Gut microbiota-dependent tryptophan metabolism: role in disease pathogenesis and therapeutic target | 2017 |
| 23 | QuantSURG | Quantitative Surgical Guidance for Colorectal Surgery using Endogenous Molecular Contrast | 2017 |
| 24 | INVESTIGERFE | Investigating the regulation of iron homeostasis by erythroferrone and therapeutic applications | 2017 |
| 25 | MIRA | Characterizing Microbe-specific Immune Responses in the pathogenesis of Autoimmunity | 2017 |
| 26 | ColoFILM | Multifunctional polymeric film-based drug delivery system for oral anti-TNF-alpha-based inflammatory bowel disease therapy | 2017 |
| 27 | FABCARB | Fermentation And behaviour of carbohydrates in the colon | 2017 |
| 28 | MArylAND | At the host-bacteria interface: Modulation of the intestinal microbiota and its metabolic activity by Card9 signalling in health and Inflammatory Bowel Diseases | 2017 |
| 29 | Glyco-Platforms | Novel smart glyco-nanomaterials as targeted therapeutics. | 2017 |
| 30 | MUC | The microbial degradation and utilization of mucin by Bacteroides in ulcerative colitis | 2017 |
| 31 | Signalling-in-NODs | Investigation of the role and mechanism of action of NOD2-mediated isoform selective PI3K signalling in gut immunity and inflammation | 2017 |
| 32 | MOWOOT | Integral Intestinal Transit Management System for chronic constipation | 2017 |
| 33 | METAMAPPER | Super-resolution genomic mapping for the microbiome | 2017 |
| 34 | NeurIMM | Neuroimmune activation as a novel therapeutic approach for IBD | 2017 |
| 35 | ETVAX | ETVAX – the first oral vaccine for protection against traveller’s diarrhoea caused by ETEC | 2017 |
| 36 | HybridHeart | Development of the first fully biocompatible, soft actuated heart: combining in situ tissue engineering and soft robotics | 2017 |
| 37 | cureCD | Function of long non-coding RNA in Crohn Disease Ulcer Pathogenesis | 2018 |
| 38 | SynBioBrain | Building biological computers from bacterial populations | 2018 |
| 39 | PREMNEC | PReterm Enteroids to determine the Mechanism of Necrotising EnteroColitis | 2018 |
| 40 | GLIAMAC | Uncovering Enteric GLIA-MACrophage communication in the intestinal homeostasis and inflammation | 2018 |
| 41 | QuanTII | Quantitative T cell Immunology and Immunotherapy | 2018 |
| 42 | TLA-Gut | Novel Personalized Cellular Therapy Approach for Immune Diseases | 2018 |
| 43 | PermeAbility | PermeAbility - A non-invasive, side-effect-free diagnostic kit for intestinal disorders | 2018 |
| 44 | MicroTher | MicroTher: Drug Discovery from the Microbiota | 2018 |
| 45 | Notid | Novel Target for Treatment of Chronic Inflammatory Diseases | 2018 |
| 46 | EUPHORIA | Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities | 2019 |
| 47 | SEPSCAV | SCAVENGING ON SEPSIS. DEVELOPMENT OF SEPSIS SPECIFIC DRUGS FROM HUMAN SCAVENGER RECEPTORS | 2019 |
| 48 | IDENSTEM | Identification and characterization of enteric nervous system stem cells | 2020 |
| 49 | I-AM-GUT | Impact of maternal Adrenomedullin on the Microbiome and Gut health: insights into preventing chronic intestinal disorders | 2019 |
| 50 | CM_GF | Biological relevance of the multiple infection unit as a novel target for antiviral development | 2020 |
| 51 | MAGI | Microbial therapy against gut inflammation | 2019 |
| 52 | SynGut | Molecular, morphological, and functional requirements for gastrointestinal serotonin release | 2020 |
| 53 | miR-IBD | Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease | 2019 |
| 54 | Help4ME | Evidence-based probiotic for Chronic Fatigue Syndrome | 2019 |
| 55 | Dignum | Innovative toilet assistive device enabling people with reduced mobility to become independent | 2019 |
| 56 | IL7RsignaTHER | Antibody-based IL-7R targeted therapies | 2020 |
| 57 | PAVE | A nanovaccine Approach for the treatment of Pancreatic Cancer | 2019 |
| 58 | NanoGut | Exploiting the pathophysiology of the gut towards innovative oral peptide delivery strategies | 2020 |
| 59 | Obsidian | Obsidian Anastomotic SafeGuard – A powerful and efficient tissue sealant method for reducing the anastomotic leak rate in colorectal surgery | 2019 |
| 60 | CAESAR | Developing Therapeutic Antibodies for Pets | 2019 |
| 61 | IBDetect | Point of Care Diagnostic Test for the Differential Diagnosis of Inflammatory Bowel Disease | 2019 |
| 62 | DISCOvERIE | Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe | 2020 |
| 63 | GUT-SEQ | Single-cell analysis of intestinal lymphocytes reveals targets for treatment of inflammatory bowel disease | 2020 |
| 64 | REpAIR | Spatio-Temporal Regulation of Inflammation and Tissue Regeneration: Studying the immune system - tissue - microbiota communication to develop targeted therapies for immune-mediated diseases and cancer | 2020 |
| 65 | GUTMAPS | Cellular cartography of the intestine in health and inflammation | 2021 |
| 66 | MUCO-IMMUN | MUCOBIOME-MEDIATED IMMUNE PATHWAYS IN INFLAMMATORY BOWEL DISEASES | 2020 |